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STATE-OF-THE-ART PAPERSSTATE-OF-THE-ART PAPER553Estimating the Risk of Radiation Exposure From Cardiac ImagingAndrew J. Einstein
Einstein summarizes the evidence base undergirding the risk estimates for radiation exposure
related to cardiac imaging. The data are derived primarily from epidemiological studies of
atomic bomb survivors, nuclear industry workers, and children exposed in utero to x-rays,
all of which have shown increased cancer risks. Studies of cohorts exposed to higher doses of
radiation in the context of medical treatment produce similar risk estimates. Using risk
projection models developed by the U.S. National Academies that incorporate these data,
the cancer risk from cardiac imaging can be estimated and compared to the benefits from
imaging.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
566imilar Outcomes for Men and Women Undergoing TAVI,
But Women May Have Better Mid-Term MortalityKentaro Hayashida, Marie-Claude Morice, Bernard Chevalier, Thomas Hovasse, Mauro Romano,
Philippe Garot, Arnaud Farge, Patrick Donzeau-Gouge, Erik Bouvier, Bertrand Cormier, Thierry Lefèvre
Hayashida and colleagues reviewed data from 260 subjects who underwent transcatheter aortic
valve implantation (TAVI) to determine if there are differences between the genders in
presentation or outcomes. Women had less coronary and peripheral disease, less previous
cardiac surgery, higher ejection fraction, and a lower EuroSCORE. Minimal femoral size,
annulus size, and valve size were smaller in women. Device success was similar despite more
frequent iliac complications in women. The 1-year survival rate was higher in women.(continued on page A-18)
FEBRUARY 7, 2012 (continued) A-18LIPID LOWERING IN WOMEN572Meta-Analysis Finds Similar Benefits for Statins in Men and WomenWilliam J. Kostis, Jerry Q. Cheng, Jeanne M. Dobrzynski, Javier Cabrera, John B. Kostis
Kostis and colleagues present a meta-analysis of sex-specific outcomes in clinical trials of
statins to address concerns that statins may not be as effective in women as they are in men.
Results were compiled from 18 trials with 141,235 patients, 40,275 women, and 21,468
cardiovascular events. The benefit of statins was statistically significant in both genders
regardless of the type of control, baseline risk, type of endpoint, and in both primary and
secondary prevention studies. All-cause mortality was also lower with statin therapy both in
women and men without significant interaction by gender. Statin therapy is associated with
significant decreases in cardiovascular events and all-cause mortality in women and men.Editorial Comment: Lori Mosca, page 583HEART FAILURE585Ursodeoxycholic Acid Improves Endothelial Function in Patients With CHFStephan von Haehling, Joerg C. Schefold, Ewa A. Jankowska, Jochen Springer, Ali Vazir, Paul R. Kalra,
Anja Sandek, Günter Fauler, Tatjana Stojakovic, Michael Trauner, Piotr Ponikowski, Hans-Dieter Volk,
Wolfram Doehner, ‡ Andrew J. S. Coats, Philip A. Poole-Wilson, Stefan D. Anker
Patients with congestive heart failure (CHF) have impaired endothelial function. This may be
related to circulating lipopolysaccharide (LPS) released from gram-negative bacteria entering
the circulation through the edematous gut wall. Ursodeoxycholic acid (UDCA), a bile acid
used in patients with cholestatic liver diseases, can surround and potentially detoxify LPS.
von Haehling and colleagues studied the effects of UDCA on endothelial function in patients
with CHF. Compared to placebo, UDCA improved peak post-ischemic blood flow. UDCA
may merit further study to both further our understanding of the pathophysiology of CHF
and as a potential therapeutic intervention.
Editorial Comment: James M. McCabe, John R. Teerlink, page 593(continued on page A-19)
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cHEART RHYTHM DISORDERS595Conduction Slowing In Left Atrium May Trigger Atrial FibrillationGautam Lalani, Amir Schricker, Michael Gibson, Armand Rostamian, David E. Krummen,
Sanjiv M. Narayan
Lalani and colleagues hypothesized that atrial fibrillation (AF) may initiate at sites exhibiting
rate-dependent slowing in conduction velocity (CV restitution). In 28 patients with AF and
3 controls, they measured bi-atrial conduction time (CT) and electrogram fractionation
during superior pulmonary vein pacing at varying cycle lengths (CL). Conduction slowed in
23 of 28 AF patients at the site of AF initiation or latest activated site. CT lengthening was
greatest in patients with persistent AF and least in control subjects. Acceleration-dependent
slowing of atrial conduction precedes AF initiation and may offer further understanding of
the functional milieu enabling AF initiation and may provide targets for AF ablation.PEDIATRIC CARDIOLOGY
607ncidence of and Risk Factors for Sudden Cardiac Death
in Children With Dilated CardiomyopathyElfriede Pahl, Lynn A. Sleeper, Charles E. Canter, Daphne T. Hsu, Minmin Lu, Steven A. Webber,
Steven D. Colan, Paul F. Kantor, Melanie D. Everitt, Jeffrey A. Towbin, John L. Jefferies,
Beth D. Kaufman, James D. Wilkinson, Steven E. Lipshultz, for the PCMR (Pediatric Cardiomyopathy
Registry) Investigators
Pahl and colleagues used data from a large registry of children with dilated cardiomyopathy
(DCM) to establish the incidence of and risk factors for sudden cardiac death (SCD) in the
pediatric DCM population. The cohort included 1,803 children diagnosed with DCM from
1990 to 2009. The 5-year incidence rates were 29% for heart transplant, 12% for nonsudden
cardiac death, 4.0% for death from unknown cause, and 2.4% for SCD. Thirty of 35 SCDs
occurred in patients who met all of these criteria: left ventricular end-systolic dimension z
score 2.6, age at diagnosis 14.3 years, and ratio of the left ventricular posterior wall
hickness to end-diastolic diameter 0.14. Patients who meet these criteria should be
onsidered for implantable cardioverter-defibrillator placement.(continued on page A-20)
FEBRUARY 7, 2012 (continued) A-20PRE-CLINICAL RESEARCH616In Vivo Detection of Oxidation-Specific Epitopes in Atherosclerotic LesionsKaren C. Briley-Saebo, Tuyen Hoang, Alexander M. Saeboe, Young Seok Cho, Sung Kee Ryu,
Eugenia Volkava, Stephen Dickson, Gregor Leibundgut, Philipp Weisner, Simone Green, Florence Casanada,
Yury I. Miller, Walter Shaw, Joseph L. Witztum, Zahi A. Fayad, Sotirios Tsimikas
Oxidation-specific epitopes (OSE) are critical in the initiation, progression and destabilization
of atherosclerotic plaques. Briley-Saebo and colleagues developed manganese (Mn) micelles
conjugated with antibodies targeting these epitopes (“targeted micelles”). In vitro studies
demonstrated that targeted Mn-micelles accumulated in macrophages when pre-exposed to
oxidized low-density lipoprotein. Strong magnetic resonance signal enhancement was
observed 48 to 72 h after administration of targeted Mn-micelles within intraplaque
macrophages in a mouse model. This study demonstrates that Mn-based molecular imaging
probes detect OSE within atherosclerotic plaques and should not have the risk of systemic
toxicity seen with gadolinium.
